20/20 Biolabs, Inc. (AIDX) stock
AIDXNasdaqServices-Testing LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3068% below fair value
$0.19+0.00 (+1.30%)
Close on Nov 17, 2026Market cap $2.39MP/E –Yield –
20/20 Biolabs total assets
Total assets on the balance sheet at the end of each period.
20/20 Biolabs's total assets was $6.12M at Jun 30, 2026. For fiscal 2025 it was $4.14M, up 15.4% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.14M | +15.4% |
| FY2024 | Dec 31, 2024 | $3.58M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $6.12M | – |
| Q1 FY2026 | Mar 31, 2026 | $5.80M | – |
| Q4 FY2025 | Dec 31, 2025 | $4.14M | – |
| Q4 FY2024 | Dec 31, 2024 | $3.58M | – |
See a number that looks wrong?